Julian Gill is a Reporter at Houston Chronicle. He specializes in medicine and healthcare, covering topics such as healthcare administration, patient care, public health, and healthcare technology. His work has been featured in notable publications including the San Antonio Express-News, Denton Media Company, Classic Rock UK, Joplin Globe, MSN, and Yahoo News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Houston, United States (Local)
Not enough data
Julian Gill's coverage largely focuses on local health-related topics, government announcements, and breaking news in the Houston area. Therefore, he may be interested in information related to healthcare issues specific to Houston and Texas. This could include data-driven insights from experts or organizations involved in healthcare provision or public health initiatives within the region.
Given his focus on citing data and covering breaking news related to local government announcements, pitches should aim at providing newsworthy updates with credible sources that can offer valuable perspectives on ongoing health-related developments in Houston and Texas. For instance, topics related to medical centers' operations, public health funding impacts, or changes within the local healthcare landscape would likely align well with Julian's coverage interests.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Empower Pharmacy calls itself the largest and most advanced compounding pharmacy in the country.
By: Julian Gill
A Houston Chronicle investigation found that the public is left in the dark when it comes to patient harm associated with the drugs.
By: Julian Gill
While Houston’s largest hospitals are all adopting AI in radiology, some move slower than others, citing high costs and uncertainty about its potential to improve health outcomes.
By: Julian Gill
Houston, with its concentration of sprawling hospitals, is primed to become a proving ground for artificial intelligence in medicine.
By: Julian Gill, Evan MacDonald
Dr. Peter Pisters, the longtime president of The University of Texas MD Anderson Cancer Center, is retiring from his post at the end of September, he announced Wednesday.
By: Julian Gill
The scale of Empower Pharmacy's production of popular GLP-1 drugs is at the center of a new federal warning letter against the Houston-based compounding pharmacy
By: Evan MacDonald, Julian Gill
Dr. David L. Callender , the president and CEO of Memorial Hermann Health System who spent nearly two decades overseeing hospitals in Houston and Galveston, will retire at the end of the year, the health system announced Monday.
By: Julian Gill
Experts say only a few university health systems have launched such comprehensive plans around AI, with the potential to impact millions of patients, students and faculty.
By: John Ferguson, Julian Gill
On Thursday, prosecutors expressed reservations about their ability to prove key elements of their case, in light of the limitations.
By: Julian Gill, John Wayne Ferguson
On Thursday, prosecutors expressed reservations about their ability to prove key elements of their case, in light of the limitations.
